These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 24164628)

  • 21. The role of adenosine signaling in sickle cell therapeutics.
    Field JJ; Nathan DG; Linden J
    Hematol Oncol Clin North Am; 2014 Apr; 28(2):287-99. PubMed ID: 24589267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Replacement of amide with bioisosteres led to a new series of potent adenosine A2A receptor antagonists.
    Yang Z; Li X; Ma H; Zheng J; Zhen X; Zhang X
    Bioorg Med Chem Lett; 2014 Jan; 24(1):152-5. PubMed ID: 24332624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists.
    Cristalli G; Lambertucci C; Marucci G; Volpini R; Dal Ben D
    Curr Pharm Des; 2008; 14(15):1525-52. PubMed ID: 18537675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
    Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
    Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A2A Adenosine Receptor Antagonists as Therapeutic Candidates: Are They Still an Interesting Challenge?
    Cacciari B; Spalluto G; Federico S
    Mini Rev Med Chem; 2018; 18(14):1168-1174. PubMed ID: 29692248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substructure-based virtual screening for adenosine A2A receptor ligands.
    van der Horst E; van der Pijl R; Mulder-Krieger T; Bender A; Ijzerman AP
    ChemMedChem; 2011 Dec; 6(12):2302-11. PubMed ID: 22021213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure of the adenosine A
    Sun B; Bachhawat P; Chu ML; Wood M; Ceska T; Sands ZA; Mercier J; Lebon F; Kobilka TS; Kobilka BK
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2066-2071. PubMed ID: 28167788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic potential of A2 and A3 adenosine receptor: a review of novel patented ligands.
    Federico S; Spalluto G
    Expert Opin Ther Pat; 2012 Apr; 22(4):369-90. PubMed ID: 22435652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonist binding and induced conformational dynamics of GPCR A2A adenosine receptor.
    Pang X; Yang M; Han K
    Proteins; 2013 Aug; 81(8):1399-410. PubMed ID: 23508898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structurally Enabled Discovery of Adenosine A
    Jazayeri A; Andrews SP; Marshall FH
    Chem Rev; 2017 Jan; 117(1):21-37. PubMed ID: 27333206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
    Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J
    J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GPCR 3D homology models for ligand screening: lessons learned from blind predictions of adenosine A2a receptor complex.
    Katritch V; Rueda M; Lam PC; Yeager M; Abagyan R
    Proteins; 2010 Jan; 78(1):197-211. PubMed ID: 20063437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosine A
    Fuentes E; Fuentes M; Caballero J; Palomo I; Hinz S; El-Tayeb A; Müller CE
    Platelets; 2018 May; 29(3):292-300. PubMed ID: 28504052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists.
    Bacilieri M; Ciancetta A; Paoletta S; Federico S; Cosconati S; Cacciari B; Taliani S; Da Settimo F; Novellino E; Klotz KN; Spalluto G; Moro S
    J Chem Inf Model; 2013 Jul; 53(7):1620-37. PubMed ID: 23705857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists.
    Shook BC; Chakravarty D; Barbay JK; Wang A; Leonard K; Alford V; Powell MT; Rassnick S; Scannevin RH; Carroll K; Wallace N; Crooke J; Ault M; Lampron L; Westover L; Rhodes K; Jackson PF
    Bioorg Med Chem Lett; 2013 May; 23(9):2688-91. PubMed ID: 23522563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding kinetics of ZM241385 derivatives at the human adenosine A2A receptor.
    Guo D; Xia L; van Veldhoven JP; Hazeu M; Mocking T; Brussee J; Ijzerman AP; Heitman LH
    ChemMedChem; 2014 Apr; 9(4):752-61. PubMed ID: 24591302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allosteric Modulation of Adenosine A
    Korkutata M; Agrawal L; Lazarus M
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of the adenosine A2A receptor attenuates experimental autoimmune myasthenia gravis severity.
    Li N; Mu L; Wang J; Zhang J; Xie X; Kong Q; Tang W; Yao X; Liu Y; Wang L; Wang G; Wang D; Jin L; Sun B; Li H
    Eur J Immunol; 2012 May; 42(5):1140-51. PubMed ID: 22539289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance of the adenosine A(2A) receptor-dopamine D(2) receptor interaction in drug addiction.
    Filip M; Zaniewska M; Frankowska M; Wydra K; Fuxe K
    Curr Med Chem; 2012; 19(3):317-55. PubMed ID: 22335511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine A₁ and A₂A receptor-mediated modulation of acetylcholine release in the mice neuromuscular junction.
    Garcia N; Priego M; Obis T; Santafe MM; Tomàs M; Besalduch N; Lanuza MA; Tomàs J
    Eur J Neurosci; 2013 Jul; 38(2):2229-41. PubMed ID: 23607735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.